Pathogenesis and malignant transformation of adenomyosis (Review)

被引:95
作者
Koike, Natsuki [1 ]
Tsunemi, Taihei [1 ]
Uekuri, Chiharu [1 ]
Akasaka, Juria [1 ]
Ito, Fuminori [1 ]
Shigemitsu, Aiko [1 ]
Kobayashi, Hiroshi [1 ]
机构
[1] Nara Med Univ, Dept Obstet & Gynecol, Kashihara, Nara 6348522, Japan
基金
日本学术振兴会;
关键词
adenomyosis; malignant transformation; pathogenesis; CLEAR-CELL ADENOCARCINOMA; ENDOMETRIOID ADENOCARCINOMA; MAST-CELLS; CYSTIC ADENOMYOSIS; BECLIN; EXPRESSION; MYOMETRIUM; CARCINOMA; ESTROGEN; RECEPTOR;
D O I
10.3892/or.2012.2184
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of our review was to identify the current information with regard to the pathogenesis and malignant transformation of adenomyosis. The current literature was reviewed by searching MEDLINE/PubMed, using the following keywords: adenomyosis, myometrium, stromal cells, malignant transformation, pathogenesis, etiology, genome-wide and microarray. Early signs of the development of adenomyosis are considered to be the penetration of stromal cells into the inner layer of the myometrium. Adenomyosis smooth muscle cells are developed, possibly, through a remodeling pathway via reactivation of coelomic epithelial cells as a result of estrogen-induced epithelial mesenchymal transition. Smooth muscle cell hyperplasia and hypertrophy are a reflection of a reaction of the surrounding tissue. The development of adenocarcinoma arising from adenomyosis is a relatively rare occurrence. In our literature review, to date, 44 cases of malignant tumors arising from adenomyosis have been documented. Studies reporting results of genetic abnormalities, epigenetic changes, monoclonal expansion, mutational analysis and the inactivation of specific tumor suppressor genes are very few in this field. In conclusion, adenomyosis can be a precursor of some carcinomas. The exact molecular mechanisms that lead to the malignant transformation are poorly understood.
引用
收藏
页码:861 / 867
页数:7
相关论文
共 73 条
[31]   Adenocarcinomas arising from uterine adenomyosis: A report of four cases [J].
Koshiyama, M ;
Suzuki, A ;
Ozawa, M ;
Fujita, K ;
Sakakibara, A ;
Kawamura, M ;
Takahashi, S ;
Fujii, H ;
Hirano, T ;
Okagaki, A ;
Nagano, T ;
Ban, C .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2002, 21 (03) :239-245
[32]  
Krutsay Miklos, 2010, Magy Onkol, V54, P179, DOI 10.1556/MOnkol.54.2010.2.13
[33]  
Kucera E, 2011, EUR J GYNAECOL ONCOL, V32, P182
[34]  
KUMAR D, 1958, J OBSTET GYNAECOL, V65, P435
[35]   DNA microarray analysis in a mouse model for endometriosis and validation of candidate factors with human adenomyosis [J].
Kusakabe, Ken Takeshi ;
Abe, Hideaki ;
Kondo, Tomohiro ;
Kato, Keiko ;
Okada, Toshiya ;
Otsuki, Yoshinori .
JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2010, 85 (02) :149-160
[36]  
Kuwashima Y., 1994, European Journal of Gynaecological Oncology, V15, P418
[37]  
Lalovic Nenad, 2011, Med Pregl, V64, P323
[38]   The pathophysiology of endometriosis and adenomyosis: tissue injury and repair [J].
Leyendecker, G. ;
Wildt, L. ;
Mall, G. .
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2009, 280 (04) :529-538
[39]   Accumulation of nerve growth factor and its receptors in the uterus and dorsal root ganglia in a mouse model of adenomyosis [J].
Li, Yan ;
Zhang, Shao-fen ;
Zou, Shi-en ;
Xia, Xian ;
Bao, Lei .
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2011, 9
[40]   Elevated Immunoreactivity against Class I Histone Deacetylases in Adenomyosis [J].
Liu, Xishi ;
Nie, Jichan ;
Guo, Sun-Wei .
GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2012, 74 (01) :50-55